Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    2019
    Nov.2019 Zhejiang Medical put on "List of key to-be-listed enterprises in Hangzhou City"

    In November 2019,Zhejiang Medical Technology Development Co., Ltd. put on 'List of key to-be-listed enterprises in Hangzhou City' 


    Nov.2019 Zhejiang Medical put on "List of key to-be-listed enterprises in Hangzhou City"
    November 1 to 3,2019 Strategic cooperation was achieved with Chinese Pharmacists Association

    November 1 to 3,2019 Strategic cooperation was achieved with Chinese Pharmacists Association,Winhealth Pharma Group expands new cooperation in rare disease field.

    November 1 to 3,2019 Strategic cooperation was achieved with Chinese Pharmacists Association
    Oct. 2019 A strategic cooperation agreement was signed with Daiichi-Sankyo

     October 31, 2019. Hong Kong Winhealth Pharma Group and Daiichi-Sankyo come to a strategic cooperation agreement on Asmeton®

    Oct. 2019 A strategic cooperation agreement was signed with Daiichi-Sankyo
    Sep. 2019 The Strategic Cooperation Agreement on the products was signed with JD.COM Pharmacy.

    September 30, 2019  Winhealth Pharma Group (Hong Kong) announced the formal establishment of a long-term strategic partnership with JD.com's self-operated pharmacy. 

    Sep. 2019 The Strategic Cooperation Agreement on the products was signed with JD.COM Pharmacy.
    Sep. 2019 Winning the "BD Influence Award"

    From September 11 to 12, 2019, the 14th China Pharmaceutical and Medtech Business Development Summit Forum, which was co-hosted by Winhealth Pharma Group, was successfully held in Yantai, Shandong province. Winhealth Pharma Group won the 'BD Influence Award'! 

    Sep. 2019  Winning the "BD Influence Award"
    Sep. 2019 Celebration on Three Million Boxes of Coniel®

    From September 6 to 9, 2019, the 'Honor and Brilliance Celebration and Sales of 3 Million Boxes of Coniel®', which was organized by Winhealth Pharma Group and Kyowa Hakko Kirin, was held in Kyoto and Osaka, Japan.

    Sep. 2019  Celebration on Three Million Boxes of Coniel®
    Sep. 2019 Strategic cooperation was achieved with Shionogi Pharmaceutical Co., Ltd.

    September 5, 2019 The strategic cooperation agreement on Flumarin was reached with Shionogi Pharmaceutical Co., Ltd. 

    Sep. 2019 Strategic cooperation was achieved with Shionogi Pharmaceutical Co., Ltd.
    Apr. 2019 Strategic cooperation was achieved with Cumberland Pharmaceuticals

    April 26, 2019 A strategic cooperation agreement was signed with Cumberland Pharmaceuticals, and an exclusive commercial license agreement for Ibuprofen Injection and other products in the Chinese market was also signed. 

    Apr. 2019  Strategic cooperation was achieved with Cumberland Pharmaceuticals
    Apr. 2019 Strategic cooperation was achieved with PharmaCept (Germany)

    April 28, 2019  An exclusive cooperation agreement was reached with PharmaCept, a German company, and the exclusive market rights for the EmboCept® series of products were obtained. 

    Apr. 2019  Strategic cooperation was achieved with PharmaCept (Germany)
    2019 Winhealth 2.0 Era begins The CDCO model comes with a strong momentum

    From April 14 to April 17, 2019, the annual grand ceremony and the 13th anniversary of Winhealth Pharma Group was held in Dragon Hotel Hangzhou, officially marking the Winhealth 2.0 Era, and starting the industry's first CDCO model! 


    2019  Winhealth 2.0 Era begins The CDCO model comes with a strong momentum
    2018
    2018 Round B financing was completed

    2018  Round B financing was completed, and the funds available totaled to about 520 million yuan


    2018  Round B financing was completed
    Dec. 2018 Strategic cooperation was achieved with Bruschettini S.R.L (Italy)

    Dec. 2018  A strategic cooperation agreement was signed with Italy's Bruschettini S.R.L, and the exclusive agency right for the product Taurolite® in China was obtained.


    Dec. 2018  Strategic cooperation was achieved with Bruschettini S.R.L (Italy)
    Nov. 2018 Signing ceremony for Contractubex®50g & Lornithine Laspartate

    November 2018  The 'Signing ceremony for Contractubex®50g & Lornithine Laspartate and strategic cooperation seminar' was held with Merz Pharma GmbH (Germany).

    Nov. 2018 Signing ceremony for Contractubex®50g & Lornithine Laspartate
    Oct. 2018 20th anniversary of marketing of Mucosolvan®

    October 20, 2018  The '20th Anniversary of marketing of Mucosolvan' was held with Boehringer Ingelheim.

    Oct. 2018  20th anniversary of marketing of Mucosolvan®
    Jul. 2018 Celebration on breakthrough of one million boxes of Coniel®

    July 25, 2018  The 'Overwhelming     Celebration on sales of one million boxes of Coniel®' was held with Kyowa Hakko Kirin China Pharmaceutical Co., Ltd. in the headquarters in Hangzhou. 

    Jul. 2018  Celebration on breakthrough of one million boxes of Coniel®
    May 2018 Winning the title of "Best Operator Platform"

    May 31, 2018  Winhealth Health Industrial Park won the title of 'Best Operator Platform' in Xiacheng District, Hangzhou. 

    May 2018  Winning the title of "Best Operator Platform"
    Mar. 2018 China Healthcare investment & Partnering Symposium(CHIPS)

    The 2018 China Healthcare investment & Partnering Symposium(CHIPS) and Hangzhou CBD Investment Forum, which was co-hosted by Winhealth Pharma Group, was successfully concluded at InterContinental Hotel in Hangzhou. 

     

    A strategic cooperation agreement was signed with Xi'an-Janssen, and the exclusive promotion right of the product Sporanox® in China was obtained. 


    Mar. 2018  China Healthcare investment & Partnering Symposium(CHIPS)
    Jan. 2018 A strategic cooperation agreement was signed with AsahiKASEI and Novartis.

    A strategic cooperation agreement was signed with AsahiKASEI, and the exclusive agency right of the product Eril® in China was obtained. 

    A strategic cooperation agreement was signed with Novartis, and the exclusive agency right for the product Hycamtin® in China was obtained. 

    Jan. 2018  A strategic cooperation agreement was signed with AsahiKASEI and Novartis.
    2017
    Dec. 2017 A strategic cooperation agreement was signed with Beaufour Ipsen

    A strategic cooperation agreement was signed with Beaufour Ipsen, and the exclusive promotion right of the product Tanakan® in China was obtained. 

    Dec. 2017  A strategic cooperation agreement was signed with Beaufour Ipsen
    Nov. 2017 A strategic cooperation agreement was signed with Boehringer Ingelheim

    November 2017  A strategic cooperation agreement was signed with Boehringer Ingelheim, and the exclusive promotion right of the product Mucosolvan® in China was obtained. 

    Nov. 2017  A strategic cooperation agreement was signed with Boehringer Ingelheim
    Oct. 2017 A strategic cooperation agreement was signed with Merz Pharma GmbH (Germany)

    October 2017  A strategic cooperation agreement was signed with Merz Pharma GmbH (Germany) , and the exclusive agency right of Contractubex® in China was obtained.

    Oct. 2017  A strategic cooperation agreement was signed with Merz Pharma GmbH (Germany)
    May 2017 A strategic cooperation agreement was signed with Kyowa Hakko Kirin

    May 2017  A strategic cooperation agreement was signed with Kyowa Hakko Kirin China Pharmaceutical Co., Ltd., and the exclusive promotion right of the product Coniel®in China was obtained.


    May 2017  A strategic cooperation agreement was signed with Kyowa Hakko Kirin
    2015
    Dec. 2015 A strategic cooperation agreement was signed with Roche

    December 2015  A strategic cooperation agreement was signed with Roche, and the exclusive promotion right of the product Oseltamivir® in China was obtained.

    Dec. 2015  A strategic cooperation agreement was signed with Roche
    Apr. 2015 A strategic cooperation agreement was signed with Pfizer

    April 2015  A strategic cooperation agreement was signed with Pfizer, and the exclusive agency right of the product Unasyn® in China was obtained.

    Apr. 2015  A strategic cooperation agreement was signed with Pfizer
    2013
    2013 The contract on "Sabal Soft Capsule" was signed

    2013  The exclusive agency right of 'Sabal Soft Capsule' in China was obtained.

    2013  The contract on "Sabal Soft Capsule" was signed
    2011
    2011 Wholly-owned acquisition of "Zhejiang Medical Technology Development Co., Ltd."

    2011  The wholly-owned acquisition of 'Zhejiang Medical Technology Development Co., Ltd.' was completed.

    2011  Wholly-owned acquisition of "Zhejiang Medical Technology Development Co., Ltd."
    2007-2010
    2007-2010 Cooperation with Qilu Pharmaceutical, LUYE Pharmaceutical, AOSAIKANG Pharmaceutical,etc.

    2007-2010  We established cooperation with Qilu Pharmaceutical, LUYE Pharmaceutical, AOSAIKANG Pharmaceutical and other pharmaceutical companies, and obtained the agency right of a number of varieties in Zhejiang.

    2007-2010 Cooperation with Qilu Pharmaceutical, LUYE Pharmaceutical,  AOSAIKANG Pharmaceutical,etc.
    2006
    Apr. 2006 Hangzhou Weining Medical Technology Co., Ltd., was established in Hangzhou

    April 2006  Hangzhou Weining Medical Technology Co., Ltd., which was the predecessor of Winhealth Pharma Group, was established in Hangzhou


    Apr. 2006  Hangzhou Weining Medical Technology Co., Ltd., was established in Hangzhou
    3rd Floor, Weijian Health Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.